Supports innovative research to discover and validate new druggable targets or biomarkers for gastric cancer, aiming to accelerate new treatment strategies.
Funder: American Association for Cancer Research
Due Dates: July 22, 2026 (Full application, 1:00 p.m. U.S. Eastern Time)
Funding Amounts: $100,000 total over 2 years; maximum $5,000 for indirect costs
Summary: Supports innovative basic, translational, or clinical research to identify and investigate novel druggable targets or biomarkers for gastric cancer.
Key Information: Applicant must be an AACR member in good standing by the submission deadline.
This grant aims to accelerate the discovery and translation of new therapeutic strategies for gastric cancer by supporting research focused on identifying and validating novel druggable targets or biomarkers. Eligible projects may be basic, translational, or clinical in nature, provided they examine targets or biomarkers relevant to gastric cancer, with an emphasis on innovation and translational potential. The ultimate goal is to advance new treatment options for patients with gastric cancer.